Third facility worldwide to receive clean bill from JCI auditor, confirming excellent quality of care and patient safety standards offered
United Arab Emirates, 31 May 2015: Evidencing a deep commitment to the well-being of its employees, Emirates Global Aluminium (“EGA”) operates on-site medical facilities at its two operating subsidiaries – Dubai Aluminium (“DUBAL”, also known as EGA Jebel Ali) and Emirates Aluminium (“EMAL”, also known as EGA Al Taweelah). Open seven days a week, these facilities cater for the organisation’s occupational health needs; provide free medical coverage to full-time EGA employees and their families as well as temporary and contractual employees; and respond to emergencies as necessary. The highest standards quality clinical and operating standards are maintained, in keeping with EGA’s commitment to excel in all aspects of the business.
Attesting to this, the in-house clinical laboratory at the EGA Jebel Ali Medical Centre was audited and received Joint Commission International (“JCI”) Accreditation mid-December 2014. The accreditation audit, which was mandated by the Dubai Health Authority (“DHA”), gave EGA Jebel Ali Medical Centre a clean bill. The JCI Auditor, who has performed over 500 audits, advised that the EGA Jebel Ali Medical Centre is only the third facility with no adverse findings – the other two were in Italy and the USA. The official certificate was presented by Dr Peter Gonsalves (Chief Medical Officer, Health & Hygiene at EGA) to Abdulla Kalban (Managing Director & Chief Executive Officer at EGA) mid-May 2015, in the presence of the clinical laboratory team.
According to Dr Gonsalves, the EGA Jebel Ali Medical Centre’s clinical laboratory performs an extensive range of routine tests and analysis in the fields of Haematology, Biochemistry, Microbiology and Serology to enable the centre’s physicians to diagnose, manage and treat diseases effectively. “The laboratory is resourced with experienced professional laboratory technicians and this achievement highlights the credibility of the clinical laboratory personnel and the EGA Jebel Ali Medical Centre as a whole,” he said. “JCI Accreditation demonstrates the efficiency, accuracy and cost effectiveness of the clinical laboratory while keeping the main focus on quality and patient safety. It also provides a framework for continuous improvement, which supports EGA’s ambition to excel.”
JCI is an independent, non-profit organisation that evaluates and accredits healthcare organisations. It was founded in the late 1990s to survey hospitals outside the USA, and currently accredits facilities in Asia, Europe, Middle East and South America. The JCI standards support a complete, accurate and objective assessment of clinical laboratory processes and management practices that provide essential services for patients. Hundreds of health care organisations have achieved the gold seal of approval as JCI Accredited entities, ranging from academic medical centres and hospitals to primary care providers and JCI partners with all of these organisations to support their quest for excellence.
The JCI accreditation process is designed to create a culture of safety and quality within an organisation that strives for continuous improvement in patient care processes and results.
“The relationship between accredited entities and JCI does not stop with the initial accreditation,” adds Dr Gonsalves. “To the contrary, JCI will continue to work with the clinical laboratory to help maintain the accreditation, keep pace with new standards and offer guidance on the continuous expectation of performance improvement that JCI accreditation promotes. This is a very positive prospect.”